: Psychotropic medications on admission up until discharge.
- Table 3 : Patients showed significant decreases o PAS: pre-ECT of 11.0 ± 5.0  post-ECT of 3.9 ± 4.3 o On CGI: pre-ECT of 6.0 ± 0.6  post-ECT of 2.1 ± 1.6 post-ECT o Statistically significant ↓ in aberrant vocalizations, motor agitation, aggressiveness, and resisting care o Statistically significant ↓ in irritability, depressive, anxiety, and delusional symptoms o Nonsignificant reduction (data on Table 3) Table 3 Author's Conclusions: -Acute ECT can be an efficacious treatment for agitation and aggression in dementia patients when behavioral and pharmacological interventions have failed -ECT used for treating a biological illness with behavioral complications -Strengths: largest case series reported to date on efficacy and safety, offers quantitative analysis of outcome with PAS and CGI scales, excludes patients with current/prior dx of mood disorder or psychotic disorder -Limitations: small sample size, retrospective assessment, no behavioral rating scales or neuropsych testing, no control group, mostly female sample, Reviewer's Critique: -Concur with author's sentiment in that there is a need for good prospective studies with enough power (n), presence of a control group, or that studies effects of ECT (acute and maintenance) on cognitive ability, quality of life Summary for Practice Implications: -ECT can be considered when patient's aggression/agitation have failed nonpharmacologic and pharmacologic interventions -Important: informed discussion with patient's family before and during all phases of treatment
